Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
These cellular discoveries do not yet alter practice; leaves open novel aldosterone-targeted therapies in cardiometabolic disease.
Jonathan S. Williams (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: